Link
Research priorities for COVID-19 vaccines to support public health decisions
Organization: Public Health Agency of Canada (PHAC)Published: 2020
"The following recommendations were developed to inform clinical trials of candidate COVID-19 vaccines to protect against infection, serious illness, and deaths caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The findings of these trials will be used to inform vaccine recommendations made by NACI and public health program decisions that will be made by Canadian jurisdictions once a COVID-19 vaccine or vaccines become available in Canada." - Research priorities for COVID-19 vaccines to support public health decisions
Resource Group:
Implementation Tool
Product Type: Guide
Research and Development
Vaccine Development
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Product Type: Guide
Category:
Vaccine Safety and Development,Research and Development,Vaccine Development,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and DevelopmentResearch and Development
Vaccine Development
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Audience:
Health Care Professional
Policy Makers
Population: Children (All)
High Risk Children
Adolescents
Adults
High Risk Adults
Pregnant and Breastfeeding People
Seniors
New and Recent Canadians
Healthcare Personnel
Region: National
Policy Makers
Population: Children (All)
High Risk Children
Adolescents
Adults
High Risk Adults
Pregnant and Breastfeeding People
Seniors
New and Recent Canadians
Healthcare Personnel
Region: National
Language:
English
AudioResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.